Phase 1 Study of Single-Agent WNT974, a First-in-class Porcupine Inhibitor, in Patients with Advanced Solid Tumours.
British journal of cancer（2021）
关键词
Targeted therapies,Tumour biomarkers,Biomedicine,general,Cancer Research,Epidemiology,Molecular Medicine,Oncology,Drug Resistance
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要